
Baker McKenzie advised a syndicate consisting of 12 international banks on a USD 7.5 billion multicurrency revolving credit facility agreement for Roche Holding AG. Deutsche Bank acted as coordinator, arranger, facility agent and swingline agent.
Roche (SWX: ROG) is a global leader in pharmaceuticals and diagnostics, with a presence in more than 100 countries worldwide. The company delivers a comprehensive portfolio of innovative medicines and diagnostic solutions across major disease areas, including oncology, immunology, neuroscience, infectious diseases and ophthalmology.